<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" > <channel><title>Comments on: Clearing the confusion on asthma medications, and why Advair and Symbicort are still safe</title> <atom:link href="http://www.kevinmd.com/blog/2008/12/clearing-confusion-on-asthma.html/feed" rel="self" type="application/rss+xml" /><link>http://www.kevinmd.com/blog/2008/12/clearing-confusion-on-asthma.html</link> <description></description> <lastBuildDate>Tue, 14 Feb 2012 17:18:00 +0000</lastBuildDate> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /> <item><title>By: laikaspoetnik</title><link>http://www.kevinmd.com/blog/2008/12/clearing-confusion-on-asthma.html#comment-88649</link> <dc:creator>laikaspoetnik</dc:creator> <pubDate>Sun, 14 Dec 2008 14:57:00 +0000</pubDate> <guid isPermaLink="false">http://clients.emmense.com/kevinmd/2008/12/clearing-the-confusion-on-asthma-medications-and-why-advair-and-symbicort-are-still-safe.html#comment-88649</guid> <description>I don&#039;t find the arguments very convincing. According to 2 Cochrane Systematic Reviews, long-acting beta2-agonist inhalers give a higher risk of serious side events, &lt;i&gt;even&lt;/i&gt; when used together with corticosteroids. See the last cochrane review about formoterol: http://is.gd/bCmh. Coincidentally I posted the podcast of this review on my blog yesterday: http://is.gd/bCo6.&lt;br/&gt;&lt;br/&gt;The conclusion of the Cochrane authors is to keep using combinations if patients feel it helps (because there is just a small increase of risk), but to discuss the discontinuation in case of no benefit. Thus in the case of Mathew&#039;s patients, the patient should be advised to continue taking Advair.&lt;br/&gt;&lt;br/&gt;I have a child with asthma (hospitalized 3 days), who controls her asthma very well by taking corticosteroids in the mite-season and beta-2 agonists when needed. I’m glad we can keep the medication to a minimum while keeping the asthma under control.</description> <content:encoded><![CDATA[<p>I don&#8217;t find the arguments very convincing. According to 2 Cochrane Systematic Reviews, long-acting beta2-agonist inhalers give a higher risk of serious side events, <i>even</i> when used together with corticosteroids. See the last cochrane review about formoterol: <a href="http://is.gd/bCmh" rel="nofollow">http://is.gd/bCmh</a>. Coincidentally I posted the podcast of this review on my blog yesterday: <a href="http://is.gd/bCo6." rel="nofollow">http://is.gd/bCo6.</a></p><p>The conclusion of the Cochrane authors is to keep using combinations if patients feel it helps (because there is just a small increase of risk), but to discuss the discontinuation in case of no benefit. Thus in the case of Mathew&#8217;s patients, the patient should be advised to continue taking Advair.</p><p>I have a child with asthma (hospitalized 3 days), who controls her asthma very well by taking corticosteroids in the mite-season and beta-2 agonists when needed. I’m glad we can keep the medication to a minimum while keeping the asthma under control.</p> ]]></content:encoded> </item> </channel> </rss>
<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using apc
Page Caching using disk: enhanced
Database Caching 2/6 queries in 0.004 seconds using memcached
Object Caching 341/345 objects using apc
Content Delivery Network via cdn.kevinmd.com

Served from: www.kevinmd.com @ 2012-02-14 14:21:04 -->
